Big Picture Bio
PrivateLast Round
Seed
Sep 17, 2026
Total Funding Raised
$1.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Big Picture Bio is a biotechnology company that develops an AI-driven platform for designing and optimizing cancer combination therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Big Picture Bio Comparables
Compare Big Picture Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 77% | |
| InSilicoTrials Technologies | 73% | |
| Nova In Silico | 71% |
Big Picture Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 17, 2026 |
Key People
Founding team and executive leadership
Big Picture Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Exceptional Ventures | Seed |
| Kadmos Capital | Seed |
| Gloucester Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2026
$1.5M round led by Exceptional Ventures and Kadmos Capital.
Recent news
Latest coverage and updates
- receives_financingOct 14, 2026
Big Picture Bio Ltd. receives $927K in non-dilutive funding from Innovate UK through its Investor Partnerships Programme and closes a £1.5 million pre-seed round to advance its designed cancer drug combinations from in silico design to wet-lab validation.
- receives_financingSep 24, 2026
Big Picture Bio Ltd. receives $1.99M Pre Seed financing and secures £700K in non-dilutive funding from Innovate UK in October 2026 to move its designed cancer drug combinations into wet-lab validation.
- is_developingSep 24, 2026
Big Picture Bio Ltd. is developing cancer combination therapies using generative AI on Sep 17th '26.
Big Picture Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Big Picture Bio's valuation, stock price, and market status.
Is Big Picture Bio a public or private company?
Big Picture Bio is a private company.
What is the current stock price of Big Picture Bio?
Big Picture Bio is a private company, so its shares have no public market price. Caplight tracks Big Picture Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Big Picture Bio worth (valuation)?
Valuation information for Big Picture Bio is not publicly available.
Can I buy Big Picture Bio stock?
Big Picture Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Big Picture Bio's last funding round?
Big Picture Bio's most recent funding round was Seed on September 17, 2026.
Who are the main investors in Big Picture Bio?
Key investors in Big Picture Bio include Exceptional Ventures, Kadmos Capital.
Will Big Picture Bio IPO soon?
No public IPO plans have been announced for Big Picture Bio.
How can I track Big Picture Bio secondary market activity?
Caplight tracks bids, offers, and trades in Big Picture Bio's shares on secondary markets.